Basic Information
| LncRNA/CircRNA Name | MIR22HG |
| Synonyms | NA |
| Region | GRCh38_17:1711493-1717174 |
| Ensemble | ENSG00000186594 |
| Refseq | NR_028502 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | CCA tissues and cell lines |
| Expression Pattern | down-regulated |
| Function Description | We first found that MIR22HG expression was significantly down-regulated in CCA tissues and cell lines. |
| Pubmed ID | 30856284 |
| Year | 2019 |
| Title | Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/?-catenin signaling pathway. |
External Links
| Links for MIR22HG | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |